Novocure Ltd. (NVCR)

81.40
1.40 1.80
NASDAQ : Health Technology
Prev Close 79.96
Open 79.87
Day Low/High 79.35 / 81.87
52 Wk Low/High 26.02 / 98.70
Volume 543.82K
Avg Volume 920.80K
Exchange NASDAQ
Shares Outstanding 98.18M
Market Cap 7.80B
EPS -0.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Xilinx, AMD, CyberArk Software: 'Mad Money' Lightning Round

Xilinx, AMD, CyberArk Software: 'Mad Money' Lightning Round

Jim Cramer takes a look at Xilinx, AMD, CyberArk Software, NovoCure, Glu Mobile, Vermillion Energy, Cliffs Natural Resources and more.

Novocure's Charts Are as Bullish As They Get, So Here's My Strategy

Novocure's Charts Are as Bullish As They Get, So Here's My Strategy

The oncology company has had a strong run and all the technical signals indicate the move higher isn't over.

Pro-Tariff, Pro-Stocks?: Cramer's 'Mad Money' Recap (Tuesday 8/13/19)

Pro-Tariff, Pro-Stocks?: Cramer's 'Mad Money' Recap (Tuesday 8/13/19)

Jim Cramer says tariff delays could spur some trade-talks progress, and at least they keep the market bears at bay for a bit.

China National Medical Products Administration Grants Innovative Medical Device Designation For Optune® In China

China National Medical Products Administration Grants Innovative Medical Device Designation For Optune® In China

Zai Lab Limited (NASDAQ: ZLAB), a Shanghai-based innovative commercial stage biopharmaceutical company, and Novocure (NASDAQ: NVCR), a global oncology company with a proprietary platform technology called Tumor Treating Fields, today announced that the...

NovoCure Moves Up In Market Cap Rank, Passing F5 Networks

NovoCure Moves Up In Market Cap Rank, Passing F5 Networks

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component NovoCure Ltd was identified as having a larger market cap than the smaller end of the S&P 500, for example F5 Networks, Inc. , according to The Online Investor.

NovoCure Looks Due for a Technical Correction

NovoCure Looks Due for a Technical Correction

Let's look at the charts and indicators in addition to following the fundamentals.

Upper Hand in the Trade War: Cramer's 'Mad Money' Recap (Tuesday 8/6/19)

Upper Hand in the Trade War: Cramer's 'Mad Money' Recap (Tuesday 8/6/19)

Jim Cramer says there may be more volatility ahead, but investors should know the U.S. still has the upper hand in the trade and currency disputes with China.

eBay, Citigroup, Funko, PayPal: 'Mad Money' Lightning Round

eBay, Citigroup, Funko, PayPal: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at eBay, Citigroup, Funko, PayPal, Carnival Cruise Lines, Hain Celestial, Zynga and more.

Novocure To Participate In Three Upcoming Investor Conferences

Novocure To Participate In Three Upcoming Investor Conferences

Novocure (NASDAQ: NVCR) announced today that it will participate in three upcoming investor conferences.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ANIK, AXTA, EIX, FDC, HOMB, NVCR, PSEC Downgrades: F, MAS Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Novocure Reports Second Quarter 2019 Financial Results And Provides Company Update

Novocure Reports Second Quarter 2019 Financial Results And Provides Company Update

Novocure (NASDAQ: NVCR) today reported financial results for the three and six months ended June 30, 2019, highlighting a track record of execution, strengthening financial performance and an advancing clinical pipeline.

Novocure Announces 10 Oral Presentations And A Special Session On Tumor Treating Fields At The 41st International Engineering In Medicine And Biology Conference

Novocure Announces 10 Oral Presentations And A Special Session On Tumor Treating Fields At The 41st International Engineering In Medicine And Biology Conference

Novocure (NASDAQ: NVCR) today announced 10 oral presentations and a special session on Tumor Treating Fields at the 41st International Engineering in Medicine and Biology (EMB) Conference, July 23 through July 27, in Berlin.

CMS Establishes 2019 Monthly Fee Schedule Amount For Optune®

CMS Establishes 2019 Monthly Fee Schedule Amount For Optune®

Novocure (NASDAQ: NVCR) today announced the U.S Centers for Medicare & Medicaid Services (CMS) has established a 2019 monthly fee schedule amount for Optune.

Medicare Releases Final Local Coverage Determination Providing Coverage Of Optune® For Newly Diagnosed Glioblastoma

Medicare Releases Final Local Coverage Determination Providing Coverage Of Optune® For Newly Diagnosed Glioblastoma

Novocure (NASDAQ: NVCR) today announced the Medicare durable medical equipment (DME) Medicare Administrative Contractors (MACs) have released a final local coverage determination (LCD) providing coverage of Optune for Medicare beneficiaries with newly...

Novocure To Report Second Quarter 2019 Financial Results

Novocure To Report Second Quarter 2019 Financial Results

Novocure (NASDAQ: NVCR) announced today that it will report financial results for the second quarter 2019 on Thursday, July 25, 2019, before the U.

German Institute For Quality And Efficiency In Healthcare Publishes Rapid Report Noting Optune's Survival Benefit For Patients With Newly Diagnosed Glioblastoma

German Institute For Quality And Efficiency In Healthcare Publishes Rapid Report Noting Optune's Survival Benefit For Patients With Newly Diagnosed Glioblastoma

Novocure (NASDAQ: NVCR) today announced that the German Institute for Quality and Efficiency in Healthcare, or IQWiG, has published its rapid report concluding that, based on a review of Novocure's EF-14 phase 3 pivotal trial, patients with newly...

Novocure Could Climb Even Further; Here's Where to Buy

Novocure Could Climb Even Further; Here's Where to Buy

The oncology company already has risen significantly this year, but its charts indicate the rally could continue.

U.S. Steel, Insperity, NovoCure: 'Mad Money' Lightning Round

U.S. Steel, Insperity, NovoCure: 'Mad Money' Lightning Round

Jim Cramer weighs in on U.S. Steel, Insperity, NovoCure, Aqua America, Universal Display, Teva Pharmaceuticals, Marathon Petroleum and more.

Can Stocks Be Fun?: Cramer's 'Mad Money' Recap (Monday 6/17/19)

Can Stocks Be Fun?: Cramer's 'Mad Money' Recap (Monday 6/17/19)

Jim Cramer says investing can be fun and rewarding -- if you really understand what you own. But keep your eye on the Fed this week.

Novocure To Participate In The Jefferies 2019 Global Healthcare Conference

Novocure To Participate In The Jefferies 2019 Global Healthcare Conference

Novocure (NASDAQ: NVCR) announced today that Bill Doyle, Novocure's Executive Chairman, will participate in the Jefferies 2019 Global Healthcare Conference on June 4, 2019, in New York City.

Medicare Issues Proposed Local Coverage Determination That Provides Coverage Of Optune® For Newly Diagnosed Glioblastoma

Medicare Issues Proposed Local Coverage Determination That Provides Coverage Of Optune® For Newly Diagnosed Glioblastoma

Novocure (NASDAQ: NVCR) today announced the Medicare durable medical equipment (DME) Medicare Administrative Contractors (MACs) have issued a proposed local coverage determination (LCD ) that provides coverage of Tumor Treating Fields, or Optune, for...

Novocure Reports First Quarter 2019 Financial Results And Provides Company Update

Novocure Reports First Quarter 2019 Financial Results And Provides Company Update

Novocure (NASDAQ: NVCR) today reported financial results for the quarter ended March 31, 2019, highlighting continued revenue growth, an advancing clinical pipeline and a strong cash position.

Novocure Announces The International Journal Of Radiation Oncology, Biology, Physics Publishes Data Demonstrating Higher Doses Of Tumor Treating Fields Improved Survival Of Newly Diagnosed Glioblastoma Patients

Novocure Announces The International Journal Of Radiation Oncology, Biology, Physics Publishes Data Demonstrating Higher Doses Of Tumor Treating Fields Improved Survival Of Newly Diagnosed Glioblastoma Patients

Novocure (NASDAQ:NVCR) announced today that the International Journal of Radiation Oncology, Biology, Physics, known in the field as the Red Journal, has published the results of an EF-14 post-hoc analysis demonstrating that higher doses of Tumor Treating...

The Expectations Game: Cramer's 'Mad Money' Recap (Monday 4/29/19)

The Expectations Game: Cramer's 'Mad Money' Recap (Monday 4/29/19)

Jim Cramer says a dip ahead of earnings can be the best protection against a hammering when a stock comes in too hot.

Twilio, Aurora Cannabis, Levi's: 'Mad Money' Lightning Round

Twilio, Aurora Cannabis, Levi's: 'Mad Money' Lightning Round

Jim Cramer weighs in on Twilio, Aurora Cannabis, Levi's, Entergy, NovoCure, Marathon Petroleum, Zix, Party City and more.

Novocure Publishes 2018 Annual Report Featuring Company's Vision, Mission And Values

Novocure Publishes 2018 Annual Report Featuring Company's Vision, Mission And Values

Novocure (NASDAQ: NVCR) announced today the publication of its 2018 Annual Report featuring its vision, mission and values, employee stories and videos, business highlights and selected financial information.

Inaugural AACR-Novocure Tumor Treating Fields Research Grant Recipients Announced At AACR Annual Meeting 2019

Inaugural AACR-Novocure Tumor Treating Fields Research Grant Recipients Announced At AACR Annual Meeting 2019

The recipients of the AACR-Novocure Tumor Treating Fields research grants were announced on April 2 at the American Association for Cancer Research (AACR) Annual Meeting 2019 in Atlanta.

TheStreet Quant Rating: C- (Hold)